Discontinuation report DELATESTRYL
Report ID | 221772 |
Drug Identification Number | 00029246 |
Brand name | DELATESTRYL |
Common or Proper name | DELATESTRYL |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE ENANTHATE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 5ml |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2024-05-15 |
Actual discontinuation date | 2024-04-25 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | 3rd party manufacturer will no longer supply |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-04-26 | English | Compare |
v4 | 2024-04-25 | French | Compare |
v3 | 2024-04-25 | English | Compare |
v2 | 2024-03-11 | French | Compare |
v1 | 2024-03-11 | English | Compare |
Showing 1 to 5 of 5